Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: A population controlled study

British Journal of Ophthalmology

Volumn 80, Issue 3, 1996, Pages 203-208

  Williamson, Tom H ^a   Rumley, Ann ^b   Lowe, Gordon D O ^b  

^a WESTERN INFIRMARY   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 7; TISSUE PLASMINOGEN ACTIVATOR;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD FLOW; BLOOD VISCOSITY; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; ERYTHROCYTE DEFORMABILITY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; IRIS; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; THROMBOGENESIS;

EID: 0029924987     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.80.3.203     Document Type: Article

References (38)

1. Rosen ES, Simmons AV, Warnes TW. Retinopathy of Waldenstrom's macroglobulinemia: photographic assessment. Am J Ophthalmol 1968; 65: 696-706.
2. Spalter HF. Abnormal serum proteins and retinal vein thrombosis. Arch Ophthalmol 1959; 62: 868-81.
3. Freel RJ, Maldonado JE, Gleich GJ. Hyperviscosity syndrome associated with immunoglobulin A myeloma. Am J Med Sci 1972; 264: 117-22.
4. Dine ME, Guay AT, Snyder LM. Hyperviscosity syndrome with IgA myeloma. Am J Med Sci 1972; 264: 111-5.
5. Kopp WL, Beirne GJ, Burns RO. Hyperviscosity syndrome in multiple myeloma. Am J Med 1967; 43: 141-6.
6. Sarnat RL, Jampol LM. Hyperviscosity retinopathy secondary to polyclonal gammopathy in a patient with rheumatoid arthritis. Ophthalmology 1986; 93: 124-7.
7. Baer MR, Stein RS, Dessypris EN. Chronic lymphocytic leukemia with hyperleukocytosis. The hyperviscosity syndrome. Cancer 1985; 56: 2865-9.
8. Mehta AB, Goldman JM, Kohner E. Hyperleucocytic retinopathy in chronic granulocytic leukaemia: the role of intensive leucapheresis. Br J Haematol 1984; 56: 661-7.
9. Thomas EL, Olk RJ, Markman M, Braine H, Patz A. Irreversible visual loss in Waldenstrom's macroglobulinaemia. Br J Ophthalmol 1983; 67: 102-6.
10. Avashia JH, Fath DF. Bilateral central retinal vein occlusion in Waldenstrom's macroglobulinemia. J Am Optom Assoc 1989; 60: 657-8.
11. Russell JA, Powles RL. The relationship between serum viscosity, hypervolaemia and clinical manifestations associated with circulating paraprotein. Br J Haematol 1978; 39: 163-75.
12. Grindle CF, Buskard NA, Newman DL. Hyperviscosity retinopathy. A scientific approach to therapy. Trans Ophthalmol Soc UK 1976; 96: 216-9.
13. Luxenberg MN, Mausolf MD. Retinal circulation in the hyperviscosity syndrome. Am J Ophthalmol 1970; 70: 588-98.
14. McGrath MA, Wechsler F, Hunyor ABL, Penny R. Systemic factors contributory to retinal vein occlusion. Arch Intern Med 1978; 138: 216-20.
15. Appiah AP, Trempe CL. Risk factors associated with branch vs central retinal vein occlusion. Ann Ophthalmol 1989; 21: 153-5, 157.
16. Ring CP, Pearson TC, Sanders MD, Wetherley Mein G. Viscosity and retinal vein thrombosis. Br J Ophthalmol 1976; 60: 397-410.
17. Piermarocchi S, Segato T, Bertoja H, Midena E, Zucchetto M, Girolami A, Procidano M, Mares M. Branch retinal vein occlusion: the pathogenetic role of blood viscosity. Ann Ophthalmol 1990; 22: 303-11.
18. Peduzzi M, Debbia A, Guerrieri F, Bolzani R. Abnormal blood rheology in retinal vein occlusion. A preliminary report. Graefes Arch Clin Exp Ophthalmol 1986; 224: 83-5.
19. Trope GE, Lowe GD, McArdle BM, Douglas JT, Forbes CD, Prentice CM, et al. Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion. Br J Ophthalmol 1983; 67: 137-42.
20. Dodson PM, Galton DJ, Hamilton AM, Blach RK. Retinal vein occlusion and the prevalence of lipoprotein abnormalities. Br J Ophthalmol 1982; 66: 161-4.
21. Wiek J, Schade M, Wiederholt M, Arntz HR, Hansen LL. Haemorheological changes in patients with retinal vein occlusion after isovolaemic haemodilution. Br J Ophthalmol 1990; 74: 665-9.
22. Chabanel A, Glacet Bernard A, Lelong F, Taccoen A, Coscas G, Samama MM. Increased red blood cell aggregation in retinal vein occlusion. Br J Haematol 1990; 75: 127-31.
23. Dodson PM, Westwick J, Marks G, Kakkar VV, Galton DJ. Beta-thromboglobulin and platelet factor 4 levels in retinal vein occlusion. Br J Ophthalmol 1983; 67: 143-6.
24. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
25. Dhote R, Buohmeyer C, Horrellou MM, Toulan P, Christoforov B. Central retinal vein thrombosis associated with resistance to activated protein C. Am J Ophthalmol 1995; 120: 388.
26. Smith WC, Lowe GD, Lee AJ, Tunstall Pedoe H. Rheological determinants of blood pressure in a Scottish adult population. J Hypertens 1992; 10: 467-72.
27. Aillaud MF, Succo E, Alessi MC, Gandois JM, Gallian P, Morange P, et al. Resistance to activated protein C - diagnostic strategy in a laboratory of haemostasis. Thromb Haemostas 1995; 74: 1197-207.
28. Williamson TH, Baxter GM, Lowe GDO. The influence of age, systemic blood pressure, smoking and blood viscosity on orbital blood velocities. Br J Ophthalmol 1995; 79: 17-22.
29. Smith R. Retinal vein occlusion and glaucoma [Editorial]. Br J Ophthalmol 1989; 73: 691.
30. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 1981; 79: 371-422.
31. Meade TW, Cooper J, Miller GJ, Howarth DJ, Stirling Y. Antithrombin III and arterial disease. Lancet 1991; 338: 850-1.
32. Peduzzi M, De Rosa V, Fonda S, Coccheri S. Haemostatic studies on retinal vein occlusion. Fibrinolytic response to venostasis as a prognostic factor for spontaneous recanalization. Thromb Res 1981; 24: 105-18.
33. Wolf S, Arend O, Bertram B, Schulte K, Kaufhold F, Teping C, et al. [Hemodilution in patients with central retinal vein thrombosis. A placebo-controlled randomized study.] Fortschr Ophthalmol 1991; 88: 35-43.
34. Glacet Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samana MM. A randomized, double masked study on the treatment of retinal vein occlusion with troxerutin. Am J Ophthalmol 1994; 118: 421-9.
35. Vannas S, Raitta C. Anticoagulant treatment of retinal vein occlusion. Am J Ophthalmol 1966; 62: 874-84.
36. Baxter GM, Williamson TH. Color Doppler flow imaging in central retinal vein occlusion: a new diagnostic technique? Radiology 1993; 187: 847-50.
37. Williamson TH, Baxter GM. Central retinal vein occlusion, an investigation by color Doppler imaging: blood velocity characteristics and prediction of iris neovascularisation. Ophthalmology 1994; 101: 1362-72.
38. Kohner EM, Hamilton AM, Bulpitt CJ, Dollery CT. Streptokinase in the treatment of central retinal vein occlusion. A controlled trial. Trans Ophthalmol Soc UK 1974; 94: 599-603.